Proton and Heavy Ion Therapy: An overview: January 2017
25
The role of this group could include developing an Australasian Particle Therapy Business Case,
including establishment of an agreed list of clinical indications for particle therapy and research as
per the UK and Danish approaches, informed by a comparative dose planning approach as
recommended in the RANZCR position paper. Other deliverables could also include determination
of current and projected service demand, evaluation of economic considerations and treatment
cost disbursement, preferred infrastructure requirements, and investigation of workforce and
training issues. Additionally, development of a bi-national data registry, to provide quantitative
data for evaluation of particle therapy clinical efficacy, cost effectiveness and safety, would likely
inform future planning of additional facilities.
Whether the reference group makes recommendations regarding the number of proton facilities
needed, or specific preferred locations or centres for construction, would form part of the Terms
of Reference of the group. Such recommendations would need to be informed by demand
modelling and stakeholder input. Nevertheless, a centralised planned approach might provide a
single body of expertise and investigation to assist national planning and introduction of PBT.
However, it should also be noted that such activity could lead to post hoc private sector
investment in PBT, which would increase PBT capacity, as has occurred in the UK following the
NHS announcement to build two public PBT facilities.
Proton and Heavy Ion Therapy: An overview: January 2017
26
Appendix A – Selected Proton Beam Facility Manufacturers: Facilities and Reported Costs
Accelerator
Manufacturer
Model and Treatment
Room Capacity
Faculties built or under
construction
Facility
Treatment
Rooms
Reported costs*
($AUD)
Hitachi Ltd
(Japan)
PROBEAT™-RT
(Single treatment room)
Hokkaido University Hospital, Japan
(opened 2016)
One
NA
PROBEAT™-V
(Two to five treatment
rooms)
Sibley Memorial Hospital, USA
(opening 2021)
Four
$182M
56
Mayo Clinic, USA
(opening 2016)
Five
$254M
57
IBA (Belgium)
Proteus ONE™
(Single treatment room)
Beaumont Hospital, USA
(opening 2017)
One
$52M
58
Proteus PLUS
(two to five treatment
rooms)
UMCG, Netherlands (opening 2017)
Two
$72M
59
Irving’s Texas Center For Proton
Therapy, USA (opened 2015)
Three
$141M
60
Mitsubishi
Electric
Corporation
(Japan)
Proton Type
Tsuyama Chuo Hospital Proton
Beam Cancer Center (opening 2016)
One
NA
Optivus Proton
Therapy Inc.
(USA)
Conforma 3000
®
(one to seven rooms)
James M. Slater, MD, Proton
Treatment and Research Center
(opened 1990)
Five
$262M
61
Sumitomo Heavy
Industries (Japan)
Proton Therapy System
Samsung Medical Center, South
Korea (opened 2016)
Three
NA
ProNova Solutions
LLC (USA)
SC360
(single to four rooms)
Scott Hamilton Proton Therapy
Center, USA (opening 2018)
Three
$131M
62
Varian Medical
Systems Inc.
(USA)
Probeam
®
Compact
(Single room)
Biopolis Oncology Center, Singapore
(opening NA)
One
NA
Probeam
®
(multi-room)
Cincinnati Children's/UC Health
Proton Therapy Center (opened
2015)
Three
$158M
63
Mevion Medical
Systems (USA)
S250™
(single room)
S. Lee Kling Proton Therapy Center,
USA (opened 2013)
One
$34M
64
S250i™
(Single room with Intensity
Modulated Proton
Therapy)
Zuidoost Nederland Protonen
Therapie Centrum, Netherlands
(opening 2018)
One
$34M
65
S250mx™
(two to four rooms)
Los Angeles Proton Center (opening
2017)
Three
NA
Protom
International
(USA)
Radiance 330
®
(one to four rooms)
Massachusetts General Hospital
(opening 2017)
One
NA
NA = not available
* International costs adjusted for inflation and converted into 2016 AUD$ using current conversion rate and reported costs may represent particle equipment costs
only, and are not inclusive of total facility costs
Proton and Heavy Ion Therapy: An overview: January 2017
27
Appendix B – Selected Carbon Ion Facility Manufacturers: Facilities and Reported Costs
Accelerator
Manufacturer
Particles
Faculties built or under
construction
Facility
Treatment
Rooms
Reported
costs ($AUD)
IBA
(C400 prototype)
Carbon ions, protons
Advanced Resource Center for
HADrontherapy in Europe, France
(opening 2018)
Three
$186M
66
Korea Institute of
Radiological and
Medical Science
Carbon ions, protons
Korea Heavy Ion Medical
Accelerator, South Korea
(opening 2017)
Three
$226M
67
European
Organization for
Nuclear Research
(CERN)
Carbon ions,
protons
Med-AUSTRON, Austria
(opened 2016)
Three
$288M
68
Lanzhou Institute
of Modern Physics
Carbon ions
Lanzhou Heavy-Ion Beam Cancer
Treatment Center, China
(opening 2016)
Three
$215M
69
Danfysik A/S
Carbon ions, protons
MIT, Marburg, Germany
(opened 2015)
Four
$202M
70
Toshiba
Corporation
Carbon ions
i-Rock Kanagawa Cancer Center,
Japan
(opened 2015)
Four
NA
Danfysik A/S
Carbon ions, protons
Shanghai Proton and Heavy Ion
Center, China
(opened 2014)
Three
$203M
70
Mitsubishi Electric
Corporation
Carbon ions
SAGA Heavy Ion Medical
Accelerator in Tosu, Japan
(opened 2013)
Three
$189M
71
GSI Helmholtz
Centre for Heavy
Ion Research
Carbon ions, oxygen ions,
protons
Heidelberg Ion-Beam Therapy
Center, Austria
(opened 2012)
Three
$187M
70
NA = not available
* International costs adjusted for inflation and converted into 2016 AUD$ using current conversion rate and reported costs may represent particle equipment costs
only, and are not inclusive of total facility costs